These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36422298)

  • 1. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
    Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
    Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
    Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
    Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
    Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
    Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metformin and statin uses with the prognosis of colon cancer: a meta-analysis.
    Xu Y; Che H; Liu J; Ye P
    Eur J Cancer Prev; 2024 Sep; 33(5):414-424. PubMed ID: 38215022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
    BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
    Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
    Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
    Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
    Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
    Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
    Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
    Henderson D; Frieson D; Zuber J; Solomon SS
    Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.